Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8%
M&A / Property

Apolo V Acquisition Corp. Amendment to Definitive Agreement with TelyRx, Inc. and Rescheduling of Special Meeting of Shareholders

By The Northwire Desk — AI Analysis Feb 20, 2026 · 12:10 AFV · 0.1
AFV · Price

Executive Summary

  • Apolo V Acquisition Corp. amended its Business Combination Agreement with TelyRx, revising the share consolidation ratio from 1 post‑share for every 45‑60 pre‑shares to a new range of 1 post‑share for every 20‑60 pre‑shares.
  • The special shareholders’ meeting originally set for February 19, 2026 has been postponed; the new meeting date is March 5, 2026 (record date remains January 20, 2026).
  • All other terms of the original Business Combination Agreement remain unchanged and in full force.

Key Details

  • Amended Business Combination Agreement (BCA): Executed on February 19, 2026 among Apolo V, TelyRx, TelyRx Finco Inc., 1001474388 Ontario Inc., and Apolo V MergerCo Inc.
  • Share Consolidation Ratio: Updated to a range of 1 post‑consolidation Apolo Share for every 20 to 60 pre‑consolidation Apolo Shares (previously 45–60).
  • Special Meeting Rescheduling:
  • Original meeting date: February 19, 2026.
  • New meeting date: March 5, 2026 at 10:00 a.m. Toronto time, held in person at Wildeboer Dellelce LLP, Suite 800, 365 Bay Street, Toronto, Ontario.
  • Record date for voting remains January 20, 2026.
  • Meeting Materials: Amended disclosure materials will be filed and mailed to shareholders after any required regulatory approvals are obtained.
  • Other Terms: No other provisions of the Business Combination Agreement have been altered; all remain in full effect.

Notable Quotes

(No executive quotes were provided in the release.)

Read the original news release →

More from

Mar 25, 2026 · 04:59

TelyRx QT Filing Clears Final Hurdles as Financing Target Slashes to $20M

Financings Mar 06, 2026 · 09:09

Apolo V Acquisition Corp. Announces Shareholder Approvals

Other Jan 21, 2026 · 16:43

Apolo V Acquisition Corp. Enters into Definitive Agreement with Telyrx, Inc.

Financings Dec 05, 2025 · 14:26

Apolo V Acquisition Corp. and TelyRx, Inc. Enter into Letter of Intent to Complete Qualifying Transaction

M&A / Property Oct 24, 2025 · 10:18

Apolo V Acquisition Corp. Completes Initial Public Offering

Financings